Targeted and global pharmacometabolomics in everolimus-based immunosuppression: association of co-medication and lysophosphatidylcholines with dose requirement-Reference-Cited by-同舟云学术

Targeted and global pharmacometabolomics in everolimus-based immunosuppression: association of co-medication and lysophosphatidylcholines with dose requirement

Published:2017-11-25 Issue:1 Volume:14 Page:
ISSN:1573-3882
Container-title:Metabolomics
language:en
Short-container-title:Metabolomics

Author:

Lesche Dorothea,Sigurdardottir Vilborg,Leichtle Alexander B.,Nakas Christos T.,Christians Uwe,Englberger Lars,Fiedler Martin,Largiadèr Carlo R.,Mohacsi Paul,Sistonen Johanna

Funder

German Society of Clinical Chemistry and Laboratory Medicine

National Institutes of Health

Katharina Huber-Steiner Foundation

Publisher

Springer Science and Business Media LLC

Subject

Clinical Biochemistry,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/article/10.1007/s11306-017-1294-8/fulltext.html

Reference45 articles.

1. Andreassen, A. K., Andersson, B., Gustafsson, F., Eiskjaer, H., Radegran, G., Gude, E., et al. (2014). Everolimus initiation and early calcineurin inhibitor withdrawal in heart transplant recipients: a randomized trial. American Journal of Transplant, 14(8), 1828–1838. https://doi.org/10.1111/ajt.12809 .

2. Azimzadeh, A. M., Lees, J. R., Ding, Y., & Bromberg, J. S. (2011). Immunobiology of transplantation: impact on targets for large and small molecules. Clinical Pharmacology & Therapeutics, 90(2), 229–242. https://doi.org/10.1038/clpt.2011.106 .

3. Boernsen, K. O., Egge-Jacobsen, W., Inverardi, B., Strom, T., Streit, F., Schiebel, H. M., et al. (2007). Assessment and validation of the MS/MS fragmentation patterns of the macrolide immunosuppressant everolimus. Journal of Mass Spectrometry, 42(6), 793–802. https://doi.org/10.1002/jms.1215 .

4. Burnham, K. P., & Anderson, D. R. (2002). Model selection and multimodel inference (1st edn.). New York: Springer.

5. Chapman, T. M., & Perry, C. M. (2004). Everolimus. Drugs, 64(8), 861–872 (discussion 873–864).

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics in Pharmacometabolomics: Towards Personalized Medication;Pharmaceuticals;2023-11-07

2. Identification of biomarkers to diagnose diseases and find adverse drug reactions by metabolomics;Drug Metabolism and Pharmacokinetics;2021-04